Kestra Advisory Services
FLGT icon

Kestra Advisory Services’s Fulgent Genetics FLGT Stock Holding History

Kestra Advisory Services’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,347
Closed -$35.4K – 3562
2025
Q4 		$35.4K Buy
+1,347
New +$34.9K ﹤0.01% 4180

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Kestra Advisory Services's FLGT Position: Q1 2026 in Review

Kestra Advisory Services sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 1,347 shares — an estimated $35.4K sold.

Kestra Advisory Services first reported a position in FLGT in Q4 2025 and held it in 1 quarter. The position peaked at $35.4K in Q4 2025. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Kestra Advisory Services reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 1,347 Fulgent Genetics shares in Q1 2026, an estimated $35.4K.
  • Kestra Advisory Services first reported a position in Fulgent Genetics in Q4 2025 and held it in 1 quarter.
  • Kestra Advisory Services's Fulgent Genetics position peaked at $35.4K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.